Both in Pharmaceuticals
Tyra Biosciences vs Ultragenyx Pharmaceutical
Over the past year TYRA returned +65.3% and RARE returned −49.5%; their daily moves had a correlation of 0.20.
TYRA +65.3% RARE −49.5%Growth of $1, one year, split-adjusted
| Metric | TYRA | RARE |
|---|---|---|
| Price | $21.98 | $15.32 |
| Market cap | $1.51B | $1.51B |
| Today | +2.47% | +6.32% |
| 1 month | −11.9% | −40.2% |
| 6 months | −36.5% | −20.6% |
| Year to date | −16.4% | −33.4% |
| 1 year | +69.5% | −47.3% |
| Revenue growth (YoY) | — | +28.1% |
| Gross margin | — | 84.1% |
| Net margin | — | −43.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.1× |
| Net cash | $353.9M | $292.0M |
| Dividend yield | — | — |
| Volatility (60d) | 87.6% | 127.9% |
| Short % of float | 29.5% | 17.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).